High expression of SNAI2 is associated with the emergence of a highly motile fulvestrantresistant phenotype and is an indicator of poor response to endocrine treatment in estrogen receptorpositive metastatic breast cancer

Carla Maria Lourenco Alves, Daniel Elias, Maria Bibi Lyng, Martin Bak, Anne Lykkesfeldt, Henrik Ditzel

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

OriginalsprogEngelsk
Publikationsdato2015
StatusUdgivet - 2015
BegivenhedAACR-NCI-EORTC SYMPOSIUM: Molecular Targets and Cancer Therapeutics - Boston, MA, USA
Varighed: 5. nov. 20159. nov. 2015

Konference

KonferenceAACR-NCI-EORTC SYMPOSIUM: Molecular Targets and Cancer Therapeutics
LandUSA
ByBoston, MA
Periode05/11/201509/11/2015

Citationsformater

Alves, C. M. L., Elias, D., Lyng, M. B., Bak, M., Lykkesfeldt, A., & Ditzel, H. (2015). High expression of SNAI2 is associated with the emergence of a highly motile fulvestrantresistant phenotype and is an indicator of poor response to endocrine treatment in estrogen receptorpositive metastatic breast cancer. Poster session præsenteret på AACR-NCI-EORTC SYMPOSIUM: Molecular Targets and Cancer Therapeutics , Boston, MA, USA.